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The structural nd immunological properties of human thrombospondins solated from platelets and from 
endothelial cells were compared. Both thromhospondins were digested with either trypsin or thermolysin, 
in the presence or absence of calcium, then injected onto a Superose 12 gei filtration column. The isolated 
the~olysin-generated fragments of throm~s~ndins were identified by radioimmunoassays using either 
different monoclonal antibodies or a polyclonal antibody directed against platelet hrombospondin. The 
results how that platelet and endothelial thrombospondins are both partially protected from trypsin diges- 
tion in the presence ofcalcium but have different trypsin and thermolysin fragmentation patterns. The ther- 
molysin-generated fragments from platelet and endothelial thrombospondins are recognized differently by 
a monoclonal ntibody whereas ail of them are identified by a polyclonal antibody. 
(Human endothelial cell, Platelet) Gelfiltration chromatography Monoclonaf antibody 
Radioimmunoassay 
1 a INTRODUCTION 
Thrombospondin, like fibronectin [I], is 
secreted by different cells including platelets and 
endothelial cells [2-51, and is composed of multi- 
ple domains which differ in their biological ac- 
tivities [4,6-91. 
All thrombospondins have been found to be im- 
munologically indistinguishable [2,3,5] and have 
similar amino acid compositions [5]. Similar 
results were obtained with fibronectins isolated 
from plasma and from cells in culture [l]. 
However, it is now apparent hat fibronectins dif- 
fer in several respects [I] including carbohydrate 
structure [l], domain structure [lo] and im- 
munological properties [lo]. 
Because of the structural and immunological 
differences between fibroncctins taken together 
+ Correspondence address 
with the apparent homology between fibron~tin 
and thrombospondin, we have compared the struc- 
tural and immunological properties of human 
thrombospondins isolated from platelets and from 
endothelial cells. 
2. MATERIALS AND METHODS 
Human endothelial cells from untraumatised 
umbilical cord veins were cultured using methods 
and materials described by Hunter et al. [l 11. Cell 
supernatants were harvested at confluence. En- 
dothelial and platelet thrombospondins were 
purified as in [12,13]. 
For the enzymatic digestion, platelet and en- 
dothelial thrombospondins were treated at a ratio 
of 1: 10 (w/w) with trypsin-TPCK (Millipore), for 
2 min at room temperature or with thermolysin 
(Sigma) at a ratio of 1:20 (w/w) for 90 min at 
37°C. Digestion was terminated by addition of 
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soybean trypsin inhibitoi (Sigma) in a 3-fold (w/w) 
excess (trypsin) or by addition of 10 mM EDTA 
(thermolysin). In some experiments thrombospon- 
dins were incubated overnight at room 
temperature with 10 mM EDTA before trypsin 
digestion. 
A Superose 12 HR lo/30 gel filtration column 
connected to an FPLC system (Pharmacia) was 
used to compare the products of trypsin and ther- 
molysin digestion of platelet and endothelial 
thrombospondins. 
For the immunodetection of isolated proteolytic 
Fig.1. Separation of tryptic fragments from human 
platelet and endothelial thrombospondins using 
Superose 12 gel filtration chromatography. (a) Purified 
thrombospondin in the presence of 10 mM EDTA. (b) 
EDTA-treated platelet throm~s~n~n digested for 
2 min at room temperature with trypsin-TPCK. (c) 
EDTA-treated endothelial thrombospondin under the 
same conditions as (b). The Superose 12 column was 
equilibrated and eluted with 20 mM triethanolamine 
buffer (pH 7.4) containing 0.35 M NaCl. The flow rate 
was 0.5 ml/min. 
fragments of thrombospondins a solid-phase 
radioimmunoassay [ 131 and a competitive radioim- 
munoassay [14] were used. 
3. RESULTS 
When human platelet or endothelial throm- 
bospondin, either calcium treated or incubated 
with 10 mM EDTA, was injected on a Superose 12 
gel filtration column, a single peak was observed at 
450 kDa (fig.la). Digestion of EDTA-treated 
platelet thrombospondin with trypsin generated 4 
major tryptic fragments (110, 40, 28 and 10 kDa) 
(fig.lb) having apparent molecular masses dif- 
ferent from those observed with EDTA-treated en- 
dothelial thrombospondin (120, 82, 54, 29 and 
11 kDa) (fig.lc). Trypsin digestion performed with 
human platelet or endothelial thrombospondin 
purified in the presence of 2 mM calcium showed 
that the 110 and 11 kDa tryptic fragments of 
EDTA-treated platelet and endothelial throm- 
bospondins were not observed in the presence of 
calcium (table 1). Digestion of calcium-treated 
Table 1 
Trypsin-generated fragments of plateret and endotheliai 
thrombospon~ns obtained in the presence or absence of 
calcium 
Molecular mass of 
fragment (kDa) 
Platelet t~ombos~ndin 
+ EDTA” 
Platelet thrombospondin 
+ Ca’+ bc 
- 450 
+ 450 110 4028 10 
- 450 
+ 450 40 28 10 
Endothelial thrombospondin - 4.50 
+ EDTA= + 450 12082542911 
Endothelial thrombospondin - 450 
-t Ca2+ bc + 450 120 82 54 29 
B Platelet and endothelial thrombospondins, incubated 
overnight at room temperature in the presence of 
10 mM EDTA, were injected on a &qWOSe 12 gel 
filtration column with (+) or without (-1 prior 
treatment with trypsin-TPCK 
b Platelet and endothelial thrombospondins, purified in 
the presence of 2 mM Ca2+, were injected on a 
Superose 12 gel filtration column with ( +) or without 
(- ) prior treatment with trypsin-TPCK 
c The trypsin to thrombos~ndin ratio was 1: 10 (wh) 
at room temperature for 2 min 
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platelet thrombospondin with thermolysin gen- Isolated thermolysin-generated fragments of 
erated 5 main fragments (110, 55, 30, 12 and platelet thrombospondin were immunodetected in 
10 kDa) (fig.2b) having apparent molecular masses a solid-phase radioimmunoassay with 4 12?- 
different from those obtained with endothelial labelled monoclonal antibodies (P9, PlO, Pll, 
thrombospondin (120, 80, 45, 25 and 10 kDa) P 12) directed against platelet thrombospondin 
(fig.2c). (table 2). 
Table 2 
Solid-phase radioimmunoassay (SPRIA) of thermolysin- 
generated fragments from platelet thrombospondin 
using different monoclonal antibodies (P9, PlO, Pll, 
P12) directed against whole platelet hrom~spondin 
Since most of the thermolysin-generated 
fragments of platelet thrombospondin were 
recognized by monoclonal antibody PlO (see table 
2), we chose to use this antibody to immunodetect 
the thermolysin-generated fragments of en- 
dothelial thrombospondin. The fragments of en- 
dothelial thrombospondin were tested in a com- 
Thermolysin-generated 
fragment? (kDa) 
450 110 55 30 12 10 
SPRIAb P9 + + + - - - 
PlO + + + - + + 
Pll + + + - +/- - 
P12 + + + - - - 
a The digestion of thrombospondin with thermolysin 
was performed in the presence of 2 mM Ca’+. The 
protease to thrombos~ndin ratio was 1:20 (w/w) at 
37*C for 90 min 
b Symboh indicate a positive (+), a slightly positive 
( + / - ) or a negative ( - ) binding of antibody 
compared to control 
Table 3 
Radioimmunoassay (RIA) of thermolysin-generated 
fragments from endothelial thrombospondin using a 
polyclonal and a monoclonal antibody (PlO) directed 
against whole platelet thrombospondin 
Thermolysin-generate 
fragmentsa (kDa) 
-..-i 
lP--’ 
44 
450 120 80 45 25 10 
RIAb polyclonal 
antibody + + + + + + 
monoclonal 
antibody + - - +/- +/- + 
a The digestion of thrombospondin with thermolysin 
was performed in the presence of 2 mM Ca’+. The 
protease to thrombospondin ratio was 1:20 (w/w) at 
37OC for 90 min 
b Symbols indicate a positive (+), a slightly positive 
(+ / -) or a negative (- ) binding of antibodies 
compared to control 
Fig.2. Separation of thermolysin-generated fragments 
from human platelet and endothelial thrombospondins 
using Superose 12 gel filtration chromatography. (a) 
Purified thrombospondin in the presence of 2 mM 
calcium. (b) Calcium-treated platelet thrombospondin 
digested for 90 min at 37*C with thermolysin. (c) 
Calcium-treated endothelial thrombos~ndin under the 
same conditions as (b). Experimental conditions of 
chromatography were similar to fig. 1. 
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petitive radioimmunoassay using both ‘251-labelled 
whole platelet thrombospondin and either a 
polyclonal or a monoclonal antibody (PlO) 
directed against platelet ~rorn~s~n~n, All the 
proteolytic fragments of endothelial thrombospon- 
din were recognized by the polyclonal antibody 
(table 3) whereas monoclonal antibody PlO only 
recognized 3 fragments (45, 25 and 10 kDa) (table 
3). 
4. DISCUSSION 
The results demonstrate that platelet and en- 
dothelial thrombospondins are partially protected 
from limited proteolysis by trypsin in the presence 
of calcium. Removal of calcium from platelet 
thrombospondin with EDTA was shown to induce 
a partial denaturation of the thrombospondin 
nodular domains and an increased sensitivity to 
proteolysis by trypsin [4], Such changes may also 
explain the increased sensitivity uf endothelial 
thrombosp~~din to proteolysis in the presence of 
EDTA. 
A clear difference in the fragmentation patterns 
of platelet and endothelial thrombospondins by 
trypsin and thermolysin was observed in this study. 
In agreement with previous studies [2,3,5], platelet 
and endothelial thrombos~ndins~ in their native 
state, were immunologically indistinguishable 
since a polyclonal antibody and a monoclonal an- 
tibody (PlO) recognized both forms of throm- 
bospondin, In addition, the use of a polyclonal an- 
tibody which recognized all the proteolyticl 
fragments of platelet and endothelial throm- 
bospondins indicates that these two forms of 
thrombospondin share common determinants. 
These results are consistent with the fact that 
platelet and endothelial thrombos~nd~s have 
similar amino acid compositions f5]. However, the 
pattern of detection of proteolytic fragments by a 
monoclonal antibody emphasises the different 
cleavage patterns of platelet and endothelial 
thrombospondins. The structural and im- 
munological bases for the differences observed 
between platelet and endothelial thrombospondins 
are unknown. However, since changes in the 
glycosylatian of glycoproteins take place in human 
endothelial cells as they approach confluence in 
culture [IS], it is conceivable that an altered 
giycosylation pattern is found in thromb~spondi~ 
isolated from culture supernatants of confluent en- 
dothelial cells. The carbohydrate moiety of human 
endothelial thrombospondin does appear to pro- 
tect partialIy the glycoprote~n against proteoIysis 
f16J. Such changes in the carbohydrate moiety of 
endothelial thrombospondin could therefore affect 
the enzymatic proteolysis of this glycoprotein and 
thus account for the structural differences ob- 
served between the two forms of ~r~mbos~ndins. 
Further work is in progress to clarify the role of 
carbohydrate structure in the polymorphism of 
platelet ahd endothelial thrombospondins. 
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